Company Name: Galapagos NV
Galapagos NV is a biotech company engaged in the discovery and development of small molecule medicines. The company’s most advanced product is being developed for the treatment of rheumatoid arthritis. In addition, the company is progressing programs in several other areas, including cystic fibrosis and inflammatory disorders.
Ticker Symbol: GLPG (NASDAQ)
Company Website: www.glpg.com
Headquarters: Mechelen, Belgium